Mitesco Inc
OTC:MITI
Intrinsic Value
Mitesco, Inc. engages in the development, production, and sale of pharmaceuticals. [ Read More ]
The intrinsic value of one MITI stock under the Base Case scenario is 0.25 USD. Compared to the current market price of 0.26 USD, Mitesco Inc is Overvalued by 3%.
Valuation Backtest
Mitesco Inc
Run backtest to discover the historical profit from buying and selling MITI stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Mitesco Inc
Current Assets | 70k |
Receivables | 10k |
Other Current Assets | 60k |
Non-Current Assets | 40k |
PP&E | 50k |
Other Non-Current Assets | -10k |
Current Liabilities | 20.4m |
Accounts Payable | 7.5m |
Accrued Liabilities | 2.2m |
Short-Term Debt | 9.4m |
Other Current Liabilities | 1.3m |
Non-Current Liabilities | 3.6m |
Other Non-Current Liabilities | 3.6m |
Earnings Waterfall
Mitesco Inc
Revenue
|
570k
USD
|
Cost of Revenue
|
-1.5m
USD
|
Gross Profit
|
-900k
USD
|
Operating Expenses
|
-8.7m
USD
|
Operating Income
|
-9.6m
USD
|
Other Expenses
|
-15.9m
USD
|
Net Income
|
-25.5m
USD
|
Free Cash Flow Analysis
Mitesco Inc
What is Free Cash Flow?
MITI Profitability Score
Profitability Due Diligence
Mitesco Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.
Score
Mitesco Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.
MITI Solvency Score
Solvency Due Diligence
Mitesco Inc's solvency score is 33/100. The higher the solvency score, the more solvent the company is.
Score
Mitesco Inc's solvency score is 33/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MITI Price Targets Summary
Mitesco Inc
According to Wall Street analysts, the average 1-year price target for MITI is 0.44 USD .
Ownership
MITI Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
MITI Price
Mitesco Inc
Average Annual Return | 106.85% |
Standard Deviation of Annual Returns | 322.47% |
Max Drawdown | -100% |
Market Capitalization | 1.5m USD |
Shares Outstanding | 5 609 010 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Mitesco, Inc. engages in the development, production, and sale of pharmaceuticals. The company is headquartered in Saint Louis Park, Minnesota and currently employs 24 full-time employees. The company went IPO on 2011-11-03. The firm is focused on acquisition of compounding pharmacy companies. The company is also focused on developing a portfolio of companies that provide healthcare technology solutions. Its operations are based on establishing medical clinics utilizing nurse practitioners under The Good Clinic name and development and acquisition of telemedicine technology. The company has opened its first The Good Clinic in Minneapolis, Minnesota.
Contact
IPO
Employees
Officers
The intrinsic value of one MITI stock under the Base Case scenario is 0.25 USD.
Compared to the current market price of 0.26 USD, Mitesco Inc is Overvalued by 3%.